Biology drives the discovery of bispecific antibodies as innovative therapeutics

S Nie, Z Wang, M Moscoso-Castro… - Antibody …, 2020 - academic.oup.com
ABSTRACT A bispecific antibody (bsAb) is able to bind two different targets or two distinct
epitopes on the same target. Broadly speaking, bsAbs can include any single molecule …

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

E Marchi, OA O'Connor - CA: A Cancer Journal for Clinicians, 2020 - Wiley Online Library
Historical advances in the care of patients with non‐Hodgkin lymphoma (NHL) have been
restricted largely to patients with B‐cell lymphoma. The peripheral T‐cell lymphomas …

Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome

K Elsayad, R Stadler, K Steinbrink… - JDDG: Journal der …, 2020 - Wiley Online Library
Radiotherapy, particularly total skin electron beam therapy (TSEB), is one of the main pillars
in the strategy for treatment of cutaneous T‐cell lymphoma (CTCL). Low‐dose TSEB has …

How we treat advanced stage cutaneous T‐cell lymphoma–mycosis fungoides and Sézary syndrome

TK Sethi, F Montanari, F Foss… - British Journal of …, 2021 - Wiley Online Library
T‐cell lymphomas (TCLs) constitute a rare subset of non‐Hodgkin lymphomas, with mycosis
fungoides/Sézary syndrome (MF/SS) being the most common subtype of cutaneous TCLs …

Therapy of peripheral T cell lymphoma: focus on nodal subtypes

PB Allen, B Pro - Current oncology reports, 2020 - Springer
Abstract Purpose of Review Peripheral T cell lymphomas (PTCLs) are a heterogeneous
group of non-Hodgkin lymphomas with inferior prognosis compared with their B cell …

Kombination von Ganzhautbestrahlung und Immuncheckpoint‐Inhibitoren: Eine vielversprechende Therapieoption bei Mycosis fungoides und Sézary‐Syndrom

K Elsayad, R Stadler, K Steinbrink… - JDDG: Journal der …, 2020 - Wiley Online Library
Die Radiotherapie, und hier insbesondere die Ganzhautbestrahlung mit Elektronen (total
skin electron beam therapy; TSEB), ist eine der wichtigsten Säulen in der Therapie kutaner T …

Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy

M Treder, U Reusch, J Marschner… - US Patent …, 2021 - Google Patents
US11167029B2 - Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy -
Google Patents US11167029B2 - Combination of a CD30XCD16 antibody with a PD-1 …